PRESS RELEASE published on 10/22/2025 at 13:30, 1 year ago Medicus Pharma Ltd. Announces First Patient Treated in United Arab Emirates (UAE) Sknjct-004 Phase 2 Clinical Study to Non-Invasively Treat Basal Cell Carcinoma (BCC) of the Skin Medicus Pharma enrolls first patient in SKNJCT-004 phase 2 clinical study for non-invasive BCC treatment in UAE with Cleveland Clinic Abu Dhabi as lead investigator Clinical Study Medicus Pharma SKNJCT-004 BCC Treatment Cleveland Clinic Abu Dhabi
BRIEF published on 10/13/2025 at 13:35, 1 year 1 month ago Medicus Pharma Ltd. présentera au Maxim Growth Summit 2025 Conférence Sur Les Biotechnologies Medicus Pharma Teverelix Sommet Maxim Growth Injection Cutanée
BRIEF published on 10/13/2025 at 13:35, 1 year 1 month ago Medicus Pharma Ltd. to Present at Maxim Growth Summit 2025 Biotech Conference Medicus Pharma Teverelix Maxim Growth Summit Skinject
PRESS RELEASE published on 10/13/2025 at 13:30, 1 year 1 month ago Medicus Pharma Ltd. to Present at The Maxim Growth Summit 2025 Medicus Pharma Ltd. CEO to join fireside chat at Maxim Growth Summit, discussing clinical development programs of Skinject (skin diseases) and Teverelix (advanced prostate cancer) Clinical Development Fireside Chat CEO Medicus Pharma Ltd. Maxim Growth Summit
BRIEF published on 10/07/2025 at 13:35, 1 year 1 month ago Medicus Pharma participera au sommet des family offices de Dubaï Développement Clinique Intelligence Artificielle Innovations Biotechnologiques Medicus Pharma Sommet Des Family Offices
BRIEF published on 10/07/2025 at 13:35, 1 year 1 month ago Medicus Pharma to Participate in Dubai Family Office Summit Artificial Intelligence Clinical Development Biotech Innovations Medicus Pharma Family Office Summit
PRESS RELEASE published on 10/07/2025 at 13:30, 1 year 1 month ago Medicus Pharma Ltd. to Present at the Family Office Summit in Dubai, UAE Dr. Raza Bokhari, Executive Chairman & CEO of Medicus, to discuss biotech innovation and wealth transfer at Family Office Summit in Dubai Biotech Innovation Family Office Summit Medicus Raza Bokhari Wealth Transfer
BRIEF published on 09/29/2025 at 13:35, 1 year 1 month ago Medicus Pharma Ltd. obtient le soutien de la FDA pour le développement de Skinject Essais Cliniques Approbation De La FDA Medicus Pharma Carcinome Basocellulaire Développement De Skinject
BRIEF published on 09/29/2025 at 13:35, 1 year 1 month ago Medicus Pharma Ltd. Gains FDA Support for Skinject Development FDA Approval Clinical Trials Medicus Pharma Basal Cell Carcinoma Skinject Development
PRESS RELEASE published on 09/29/2025 at 13:30, 1 year 1 month ago Medicus Pharma Ltd. Receives Positive Feedback From the Food and Drug Adminstration (FDA) Type C Meeting Supporting the Development of Skinject FDA agrees to 505(b)(2) pathway for Medicus Pharma's Skinject D-MNA to treat BCC, positive Type C meeting feedback, SKNJCT-003 patient recruitment aims, EOP2 request in Q1 2026 FDA Clinical Study Medicus Pharma Skinject D-MNA BCC
Published on 11/14/2026 at 12:56, 13 hours 22 minutes ago Gabriel Announces Dismissal of ICSID Annulment Application
Published on 11/14/2026 at 01:30, 1 day ago NuRAN Wireless Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency
Published on 11/14/2026 at 00:40, 1 day 1 hour ago BEACN Announces Annual General and Special Meeting Results
Published on 11/14/2026 at 00:35, 1 day 1 hour ago American Hotel Income Properties REIT LP Reports Q3 2026 Results
Published on 11/14/2026 at 00:00, 1 day 2 hours ago SLAM Announces Proposed Extension of Warrant Expiry Dates
Published on 11/13/2026 at 23:24, 1 day 2 hours ago EQS-Adhoc: ASOS PLC: Repurchase of £90m of 2028 Convertible Bonds
Published on 11/13/2026 at 21:52, 1 day 4 hours ago EQS-Adhoc: Airbus reports share buyback transactions 9-13 November 2026
Published on 11/13/2026 at 19:08, 1 day 7 hours ago EQS-Adhoc: CHAPTERS Group AG: Successful Completion of Private Placement of the Capital Increase from Authorized Capital Resolved on November 13, 2026
Published on 11/13/2026 at 19:00, 1 day 7 hours ago Assemblée générale ordinaire des actionnaires le 18 décembre 2026
Published on 11/13/2026 at 11:35, 1 day 14 hours ago ENGIE and Google to partner on energy solutions for a potential data center project near Châteauroux, France
Published on 11/13/2026 at 11:35, 1 day 14 hours ago ENGIE et Google s’associent pour développer les solutions énergétiques d’un projet de data center envisagé près de Châteauroux, en France
Published on 11/13/2026 at 08:00, 1 day 18 hours ago Résultats trimestriels au 30 septembre 2026 - ANR par action : 101,54 €, en progression de + 7,8 % sur 9 mois - Capitaux propres consolidés : 772 M€
Published on 11/12/2026 at 23:12, 2 days 3 hours ago Belgrano continues the implementation of its public share buyback offer (OPRA)